Shutting the door on COVID-19

By Professor Jason Mercer – Institute of Microbiology and Infection The path is clear: a proportion of the UK population will be infected by COVID-19. Echoing China and Italy, the vast majority of people infected will present with no or mild symptoms and recover quickly. Others, largely people over 60 years of age or those harboring … Continue reading “Shutting the door on COVID-19”

Antigens developed to aid fightback against coronavirus

The Native Antigen Company, one of the world’s leading suppliers of reagents that enables research into vaccines and diagnostics for emerging and endemic infectious diseases, has announced the commercial introduction of its Novel Coronavirus antigens, derived from the emerging Wuhan strain. These recombinant proteins offer scientists high-quality reagents to support ongoing infectious disease research, and … Continue reading “Antigens developed to aid fightback against coronavirus”